SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-000904
Filing Date
2024-03-06
Accepted
2024-03-06 16:32:25
Documents
1
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3824
  Complete submission text file 0000905148-24-000904.txt   5216
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address
Palani Santhosh (Reporting) CIK: 0002013475 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41551 | Film No.: 24726415